Is cryptogenic cirrhosis different from NASH cirrhosis?

被引:66
作者
Thuluvath, Paul J. [1 ,2 ,3 ]
Kantsevoy, Sergey [1 ,2 ,3 ]
Thuluvath, Avesh J. [4 ]
Savva, Yulia [1 ]
机构
[1] Mercy Med Ctr, Inst Digest Hlth & Liver Dis, Baltimore, MD 21202 USA
[2] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
UNOS; Autoimmune hepatitis; Alcoholic cirrhosis; Age and gender matched; FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; RISK-FACTORS; NATURAL-HISTORY; TRANSPLANTATION; OBESITY; ASSOCIATION; PREVALENCE; HEPATITIS;
D O I
10.1016/j.jhep.2017.11.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background & Aims: We hypothesized that patients currently diagnosed with cryptogenic cirrhosis (CC) have truly 'cryptogenic' liver disease, which is unlikely to have evolved from NASH. The aim of this study is to characterize patients with CC, and compare their characteristics to patients with cirrhosis of other etiologies. Methods: To investigate this, we compared the clinical characteristics of adults with CC (n = 7,999) to those with cirrhosis caused by non-alcoholic steatohepatitis (NASH) (n = 11,302), alcohol (n = 21,714) and autoimmune hepatitis (n = 3,447), using the UNOS database from 2002-16. We performed an age, gender and year of listing matched comparison of CC and NASH (n = 7,201 in each group), and also stratified patients by the presence of obesity or diabetes mellitus (DM). Results: From 2002 to 2016, patients listed with a diagnosis of NASH increased from about 1% to 16% while CC decreased from 8% to 4%. A logistic regression model using the entire United Network for Organ Sharing data (n = 138,021) suggested that the strongest predictors of NASH were type 2 DM, obesity, age >= 60 years, female gender and white race. Type 2 DM was more common in patients with NASH (53%) than those with CC (29%), alcoholic cirrhosis (16%) and autoimmune hepatitis (16%), and obesity was more common in NASH (65.3%) compared to the other three groups (33-42%). There were more white individuals (82.3%) in the NASH group and a lower prevalence of black, Hispanic and Asian individuals, compared to the other three groups. Hepatocellular carcinoma was more commonly seen in NASH (19% vs. 9-13% in the other groups) and this is not influenced by obesity and type 2 DM. The differences between CC and NASH remained unchanged even when two groups were matched for age, gender and year of listing, or when stratified by the presence or absence of obesity or type 2DM. Conclusions: Based on risk perspectives, CC should not be equated with the term 'NASH cirrhosis'. Lay summary: We hypothesized that cryptogenic cirrhosis is a distinct condition from cirrhosis caused by non-alcoholic steatohepatitis (NASH). By comparing cryptogenic cirrhosis with cirrhosis of other causes, we found clear clinical differences. Therefore, cryptogenic cirrhosis should not be considered the same as NASH cirrhosis. Further investigations are required to identify unknown causes of cirrhosis. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:519 / 525
页数:7
相关论文
共 33 条
[1]
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR) [J].
Adam, Rene ;
Karam, Vincent ;
Delvart, Valerie ;
O'Grady, John ;
Mirza, Darius ;
Klempnauer, Jurgen ;
Castaing, Denis ;
Neuhaus, Peter ;
Jamieson, Neville ;
Salizzoni, Mauro ;
Pollard, Stephen ;
Lerut, Jan ;
Paul, Andreas ;
Carlos Garcia-Valdecasas, Juan ;
Juan Rodriguez, Fernando San ;
Burroughs, Andrew .
JOURNAL OF HEPATOLOGY, 2012, 57 (03) :675-688
[2]
The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis [J].
Ascha, Mustafa S. ;
Hanouneh, Ibrahim A. ;
Lopez, Rocio ;
Tamimi, Tarek Abu-Rajab ;
Feldstein, Ariel F. ;
Zein, Nizar N. .
HEPATOLOGY, 2010, 51 (06) :1972-1978
[3]
Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation [J].
Ayata, G ;
Gordon, FD ;
Lewis, D ;
Pomfret, E ;
Pomposelli, JJ ;
Jenkins, RL ;
Khettry, U .
HUMAN PATHOLOGY, 2002, 33 (11) :1098-1104
[4]
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[5]
Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].
Caldwell, SH ;
Oelsner, DH ;
Iezzoni, JC ;
Hespenheide, EE ;
Battle, EH ;
Driscoll, CJ .
HEPATOLOGY, 1999, 29 (03) :664-669
[6]
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States [J].
Charlton, Michael R. ;
Burns, Justin M. ;
Pedersen, Rachel A. ;
Watt, Kymberly D. ;
Heimbach, Julie K. ;
Dierkhising, Ross A. .
GASTROENTEROLOGY, 2011, 141 (04) :1249-1253
[7]
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis [J].
Contos, MJ ;
Cales, W ;
Sterling, RK ;
Luketic, VA ;
Shiffman, ML ;
Mills, AS ;
Fisher, RA ;
Ham, J ;
Sanyal, AJ .
LIVER TRANSPLANTATION, 2001, 7 (04) :363-373
[8]
THE NATURE AND PROGNOSIS OF SEVERE CRYPTOGENIC CHRONIC ACTIVE HEPATITIS [J].
CZAJA, AJ ;
CARPENTER, HA ;
SANTRACH, PJ ;
MOORE, SB ;
HOMBURGER, HA .
GASTROENTEROLOGY, 1993, 104 (06) :1755-1761
[9]
Duclos-Vallee JC, 2002, HUM PATHOL, V33, P1098
[10]
NAFLD Recurrence in Liver Transplant Recipients [J].
Dureja, Parul ;
Mellinger, Jessica ;
Agni, Rashmi ;
Chang, Faye ;
Avey, Gregory ;
Lucey, Michael ;
Said, Adnan .
TRANSPLANTATION, 2011, 91 (06) :684-689